 Checkmate Pharmaceuticals Inc NASDAQ: CMPI shares are trading higher by 328.40 to 10.41 during Tuesdays pre-market session after Regeneron Pharmaceuticals Inc NASDAQ: REGN announced a deal to acquire the company for 10.50 per share in cash. Checkmates lead investigational candidate. 